Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
2010 · Molecular Therapy · 2,478 citations
https://doi.org/10.1038/mt.2010.24
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
104
Citations
2
h-index
2
i10-index
Richard A. Morgan is an academic researcher from BioNTech (United States). The author has contributed to research in topics: CAR-T cell therapy research & Hemophilia Treatment and Research & Hepatitis B Virus Studies. The author has an h-index of 2, co-authored 3 publications.
https://doi.org/10.1038/mt.2010.24
https://doi.org/10.1038/nrc2355
https://doi.org/10.1056/nejmoa1817226
Click to start Chat